Developing novel strategies to target B-cell malignancies

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2013, Pages 366-372

  Fowler, Nathan ^a   Oki, Yasuhiro ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME INHIBITOR; PROTEIN KINASE INHIBITOR; TARGET OF RAPAMYCIN KINASE;

ANTAGONISTS AND INHIBITORS; CLASSIFICATION; DRUG DESIGN; DRUG EFFECTS; EXPERIMENTAL THERAPY; HUMAN; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MOLECULARLY TARGETED THERAPY; PROCEDURES; SIGNAL TRANSDUCTION; TRENDS; TUMOR MICROENVIRONMENT;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; DRUG DESIGN; HUMANS; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MOLECULAR TARGETED THERAPY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEASOME INHIBITORS; PROTEIN KINASE INHIBITORS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; THERAPIES, INVESTIGATIONAL; TOR SERINE-THREONINE KINASES; TUMOR MICROENVIRONMENT;

EID: 84897460610     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.1200/EdBook_AM.2013.33.366     Document Type: Review

References (0)